Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SeaStar Medical Holding (ICU) Income from Continuing Operations (2023 - 2025)

Historic Income from Continuing Operations for SeaStar Medical Holding (ICU) over the last 3 years, with Q3 2025 value amounting to -$3.5 million.

  • SeaStar Medical Holding's Income from Continuing Operations rose 2246.54% to -$3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.7 million, marking a year-over-year increase of 5424.87%. This contributed to the annual value of -$24.8 million for FY2024, which is 534.46% up from last year.
  • Per SeaStar Medical Holding's latest filing, its Income from Continuing Operations stood at -$3.5 million for Q3 2025, which was up 2246.54% from -$2.0 million recorded in Q2 2025.
  • In the past 5 years, SeaStar Medical Holding's Income from Continuing Operations ranged from a high of -$2.0 million in Q2 2025 and a low of -$12.7 million during Q1 2024
  • Its 3-year average for Income from Continuing Operations is -$5.5 million, with a median of -$4.4 million in 2024.
  • Per our database at Business Quant, SeaStar Medical Holding's Income from Continuing Operations plummeted by 7893.18% in 2024 and then surged by 7029.22% in 2025.
  • SeaStar Medical Holding's Income from Continuing Operations (Quarter) stood at -$9.5 million in 2023, then skyrocketed by 53.27% to -$4.4 million in 2024, then grew by 21.43% to -$3.5 million in 2025.
  • Its Income from Continuing Operations was -$3.5 million in Q3 2025, compared to -$2.0 million in Q2 2025 and -$3.8 million in Q1 2025.